Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Krystal Biotech	Cellectis	Inhibrx	Atara Biotherapeutics	Adverum Biotechnologies
Symbol	NASDAQ:KRYS	NASDAQ:CLLS	NASDAQ:INBX	NASDAQ:ATRA	NASDAQ:ADVM
Price Information
Current Price	$71.65	$19.31	$26.56	$15.89	$10.96
52 Week Range	Buy	Hold	Buy	Buy	Buy
MarketRank™
Overall Score	1.5	1.2	1.7	1.6	1.7
Analysis Score	3.5	3.2	3.5	4.4	3.4
Community Score	2.5	2.9	3.3	2.8	2.4
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.0	0.8	0.0	2.5
Earnings & Valuation Score	0.0	0.0	0.6	0.6	0.0
Analyst Ratings
Consensus Recommendation	Buy	Hold	Buy	Buy	Buy
Consensus Price Target	$101.00	$24.25	$34.67	$35.88	$23.50
% Upside from Price Target	40.96% upside	25.58% upside	30.52% upside	125.77% upside	114.42% upside
Trade Information
Market Cap	$1.64 billion	$855.67 million	$1.10 billion	$1.24 billion	$1.10 billion
Beta	1.2	2.59	N/A	2.65	1.72
Average Volume	171,187	447,061	172,968	876,792	849,827
Sales & Book Value
Annual Revenue	N/A	$22.99 million	N/A	N/A	$250,000.00
Price / Sales	N/A	35.69	N/A	N/A	4,287.38
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$11.72 per share	$8.37 per share	N/A	$5.37 per share	$2.71 per share
Price / Book	N/A	2.31	N/A	N/A	4.04
Profitability
Net Income	$-19,090,000.00	$-102,090,000.00	N/A	$-290,980,000.00	$-64,490,000.00
EPS	($1.20)	($2.41)	N/A	($5.67)	($1.01)
Trailing P/E Ratio	N/A	N/A	0.00	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-110.52%	N/A	N/A	N/A
Return on Equity (ROE)	-10.72%	-23.56%	N/A	-94.86%	-32.23%
Return on Assets (ROA)	-10.40%	-16.69%	N/A	-82.17%	-28.02%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.10%	0.18%	N/A	N/A
Current Ratio	39.96%	6.11%	3.80%	9.41%	28.53%
Quick Ratio	39.96%	6.00%	3.80%	9.41%	28.53%
Ownership Information
Institutional Ownership Percentage	73.05%	33.30%	36.63%	N/A	97.41%
Insider Ownership Percentage	27.40%	16.41%	N/A	4.30%	12.40%
Miscellaneous
Employees	51	253	75	429	114
Shares Outstanding	22.20 million	42.49 million	37.71 million	83.62 million	97.80 million
Next Earnings Date	5/3/2021 (Estimated)	3/4/2021 (Confirmed)	3/5/2021 (Estimated)	5/5/2021 (Estimated)	5/27/2021 (Estimated)
Optionable	Not Optionable	Optionable	Not Optionable	Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources